We developed a model to assess the risk of developing CHD with EM based on the methylation levels of imprinted genes SNRPN, ZAC1, and INPP5F. CHD with EM samples were categorized according to the quartile of methylation level found in the control samples. Here, SNRPN is linked to coronary artery disorder.